Knownwell, a metabolic care startup, is raising $25 million in funding led by CVS Health Ventures, CEO Brooke Boyarsky Pratt tells Axios Pro exclusively.
Why it matters: While GLP-1 usage grows, there's still a dearth of treatment options for patients with an overweight or obesity diagnosis.
